Logistic Properties of the Americas said it will sell a logistics park in Lima, Pera for $145 million. The stock surged 65% to $5.17 after the bell. Legend Biotech said it would sell $225 million ...
Gene therapy maker uniQure is one step closer to marketing its treatment for Huntington’s disease.
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
Revolution Medicines (RVMD 4.15%) looks unstoppable. The clinical-stage biotech company has been riding the wave of ...
Shares Nasdaq Biotechnology ETF is rated a Hold with modest valuation but lackluster momentum and unfavorable market themes.
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?
A clinical-stage innovator faces off against an established biotech powerhouse, each with distinct financials and risk ...
It's important to consider your comfort with risk before diving in.
Merck (NYSE: MRK), and Pfizer (NYSE: PFE) are among the largest pharmaceutical companies in the world. The first focuses ...
Some things are inherently risky. Feeding a bear while camping and texting while driving come to mind. So does investing in biotech stocks. However, not every biotech stock is super-risky. Mirum ...
In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential.
In this article, we will be taking a look at the 8 Oversold Biotech Stocks to Invest In Now. On February 5, J.P. Morgan revealed major themes that are expected to affect healthcare in 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results